Supplemental Cash Flow Statement Information (Tables)

6 Months Ended

Jun. 30, 2020

Supplemental Cash Flow Elements [Abstract]

Restrictions on Cash and Cash Equivalents

The following table summarizes the Company’s cash, cash equivalents and restricted cash as of June 30, 2020 and December 31, 2019:


	June 30, 2020		December 31, 2019
	(in thousands)
Cash and cash equivalents	$	191,124	$	382,515
Restricted cash	1,849		1,849
Total	$	192,973	$	384,364

The following table summarizes the amounts designated as collateral for letters of credit related to the lease of office and laboratory space in Cambridge, Massachusetts at both June 30, 2020 and December 31, 2019:


Property Location	Letter of Credit Amount		Balance Sheet Classification
	(in thousands)
320 Bent Street	$	748	Non-Current Asset
301 Binney Street, Fifth Floor	1,101		Non-Current Asset
Total	$	1,849

Schedule of Cash and Cash Equivalents

The following table summarizes the Company’s cash, cash equivalents and restricted cash as of June 30, 2020 and December 31, 2019:


	June 30, 2020		December 31, 2019
	(in thousands)
Cash and cash equivalents	$	191,124	$	382,515
Restricted cash	1,849		1,849
Total	$	192,973	$	384,364

MOMENTA PHARMACEUTICALS INC 10-Q